Ultrasonic electroconductive drug penetration technique combined with drugs in patients with pulmonary tuberculosis

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100053555

Enrollment

Unknown

Registered

2021-11-24

Start date

2021-12-01

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

Intervention group:Ultrasound conductance drug penetration anti-tuberculosis drugs + conventional anti-tuberculosis treatment

Control group:Anti-tuberculosis conventional treatment

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Clinical diagnosis of pulmonary tuberculosis (positive sputum culture); 2. Aged 18-70 years; 3. Informed consent, voluntary participation.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or lactation, allergic constitution; 2. Patients with cardiovascular, liver and kidney diseases and mental patients; 3. Patients with extrapulmonary tuberculosis; 4. Patients with contraindications to ultrasound conductivity meter, such as systemic skin damage.

Design outcomes

Primary

Measure	Time frame
Time to sputum conversion.;Degree of absorption of tuberculosis cavity lesions;Overall effective rate of treatment;	—

Countries

China

Contacts

Public ContactXue Miao

876858067@qq.com+86 18980606198

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026